Related references
Note: Only part of the references are listed.AIDS Vaccines and Preexposure Prophylaxis: Is Synergy Possible?
Jean-Louis Excler et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2011)
Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys
Jinyan Liu et al.
JOURNAL OF VIROLOGY (2010)
Immunology and the elusive AIDS vaccine
Herbert W. Virgin et al.
NATURE (2010)
Targeting early infection to prevent HIV-1 mucosal transmission
Ashley T. Haase
NATURE (2010)
Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer
Lisa M. Miller Jenkins et al.
NATURE CHEMICAL BIOLOGY (2010)
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
Quarraisha Abdool Karim et al.
SCIENCE (2010)
Human Immunodeficiency Virus Type 1 Nucleocapsid Inhibitors Impede trans Infection in Cellular and Explant Models and Protect Nonhuman Primates from Infection
Gregory S. Wallace et al.
JOURNAL OF VIROLOGY (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Targeting the Viral Nucleocapsid Protein in Anti-HIV-1 Therapy
Yves Mely et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
HIV prevention 6 - Coming to terms with complexity: a call to action for HIV prevention
Peter Piot et al.
LANCET (2008)
A Recoding Method to Improve the Humoral Immune Response to an HIV DNA Vaccine
Yaoxing Huang et al.
PLOS ONE (2008)
Nucleocapsid protein function in early infection processes
James A. Thomas et al.
VIRUS RESEARCH (2008)
Preclinical evaluation of a zinc finger inhibitor targeting lentivirus nucleocapsid protein in SIV-infected monkeys
Marco L. Schito et al.
CURRENT HIV RESEARCH (2006)
Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys
NL Letvin et al.
SCIENCE (2006)
In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials
D Tien et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2005)
Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges
RR Regoes et al.
PLOS MEDICINE (2005)
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda
MJ Wawer et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Studies on the mechanism of inactivation of the HIV-1 nucleocapsid protein NCp7 with 2-mercaptobenzamide thioesters
LMM Jenkins et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Optimization of unique, uncharged thioesters as inhibitors of HIV replication
P Srivastava et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys
NL Letvin et al.
JOURNAL OF VIROLOGY (2004)
In vivo antiviral activity of novel human immunodeficiency virus type 1 nucleocapsid p7 zinc finger inhibitors in a transgenic murine model
ML Schito et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2003)
Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infection
ZQ Zhang et al.
JOURNAL OF VIROLOGY (2002)
HIV preferentially infects HIV-specific CD4+ T cells
DC Douek et al.
NATURE (2002)
A human immunodeficiency virus-transgenic mouse model for assessing interventions that block microbial-induced proviral expression
ML Schito et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda
RH Gray et al.
LANCET (2001)
Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIVSF162P3
JM Harouse et al.
JOURNAL OF VIROLOGY (2001)
Viral load and heterosexual transmission of human immunodeficiency virus type 1
TC Quinn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
